MedPath

Universities of Cologne

Universities of Cologne logo
🇩🇪Germany
Ownership
Private
Established
1388-01-01
Employees
251
Market Cap
-
Website
http://www.portal.uni-koeln.de/uoc_home.html?l=1

Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse

Phase 2
Recruiting
Conditions
Multiple Myeloma
Interventions
First Posted Date
2020-12-07
Last Posted Date
2022-04-05
Lead Sponsor
University of Cologne
Target Recruit Count
160
Registration Number
NCT04656951
Locations
🇩🇪

University of Cologne, Cologne, Germany

Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients

Phase 2
Completed
Conditions
Cancer
Dyspnea, Paroxysmal
Interventions
First Posted Date
2020-11-19
Last Posted Date
2020-11-19
Lead Sponsor
University of Cologne
Target Recruit Count
10
Registration Number
NCT04635852
Locations
🇩🇪

University Hospital Göttingen Center of Palliative Medicine, Göttingen, Hessen, Germany

🇩🇪

Study Center Palliative Medicine, Cologne, NRW, Germany

🇩🇪

Hospital Essen- Mitte, Departement of Palliative Medicine, Essen, NRW, Germany

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation

Phase 1
Terminated
Conditions
SARS-CoV-2 Infection
Interventions
First Posted Date
2020-11-17
Last Posted Date
2024-10-03
Lead Sponsor
University of Cologne
Target Recruit Count
45
Registration Number
NCT04631705
Locations
🇩🇪

University Hospital Gießen and Marburg, Gießen, Hesse, Germany

🇩🇪

University Hospital Cologne, Cologne, NRW, Germany

🇩🇪

University Hospital Düsseldorf, Düsseldorf, Germany

and more 3 locations

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion

Phase 1
Completed
Conditions
SARS-CoV-2 Infection
Interventions
Biological: DZIF-10c
Other: Placebo
First Posted Date
2020-11-17
Last Posted Date
2024-04-08
Lead Sponsor
University of Cologne
Target Recruit Count
57
Registration Number
NCT04631666
Locations
🇩🇪

University Hospital Cologne, Cologne, NRW, Germany

Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease

Not Applicable
Completed
Conditions
Respiratory Insufficiency
Heart Failure
Lung Diseases, Interstitial
Palliative Medicine
Dyspnea
Pulmonary Disease, Chronic Obstructive
Lung Diseases
Palliative Care
Breathlessness
Neoplasms
Interventions
Behavioral: Cognitive and Behavioral intervention for the Management of Episodic Breathlessness
First Posted Date
2020-11-16
Last Posted Date
2020-11-16
Lead Sponsor
University of Cologne
Target Recruit Count
49
Registration Number
NCT04630743
Locations
🇩🇪

University Hospital of Cologne, Cologne, NRW, Germany

Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

Phase 2
Recruiting
Conditions
Pancreatic Cancer
Metastasis
Surgery
Oligometastatic Disease
Interventions
Drug: nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA)
First Posted Date
2020-11-05
Last Posted Date
2024-01-12
Lead Sponsor
University of Cologne
Target Recruit Count
150
Registration Number
NCT04617457
Locations
🇩🇪

University Aachen, Aachen, Germany

🇩🇪

University of Berlin, Charité, Campus Benjamin-Franklin, Berlin, Germany

🇩🇪

University of Bonn, Bonn, Germany

and more 8 locations

Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps

Completed
Conditions
Catheter-Related Blood Stream Infection
CLABSI - Central Line Associated Bloodstream Infection
Interventions
Device: 70% isopropyl alcohol-impregnated catheter caps
First Posted Date
2020-09-01
Last Posted Date
2025-04-06
Lead Sponsor
University of Cologne
Target Recruit Count
598
Registration Number
NCT04534348
Locations
🇩🇪

University Hospital of Cologne, Cologne, Germany

ImPACt on Invasive Fungal Infections by Immune Checkpoint Inhibition

Completed
Conditions
Invasive Fungal Infections
Interventions
Other: No intervention
First Posted Date
2020-08-31
Last Posted Date
2022-11-01
Lead Sponsor
University of Cologne
Target Recruit Count
50
Registration Number
NCT04533087
Locations
🇩🇪

Klinikum der Universität zu Köln, Köln, Germany

Short Term Induction of Ketosis in PKD

Not Applicable
Completed
Conditions
ADPKD
Interventions
Other: Ketogenic diet
Other: Fasting
First Posted Date
2020-07-15
Last Posted Date
2021-09-14
Lead Sponsor
University of Cologne
Target Recruit Count
10
Registration Number
NCT04472624
Locations
🇩🇪

Department II of Internal Medicine, University Hospital Cologne, Cologne, Germany

German Register of Outpatient Parenteral Antibiotic Therapy

Conditions
Implementation of OPAT in Germany
Interventions
Procedure: Outpatient Parenteral Antibiotic Therapy
First Posted Date
2020-06-02
Last Posted Date
2020-11-05
Lead Sponsor
University of Cologne
Target Recruit Count
600
Registration Number
NCT04413396
Locations
🇩🇪

University Hospital of Cologne, Cologne, Germany

© Copyright 2025. All Rights Reserved by MedPath